Agronomics
VC Fund
Douglas, United Kingdom
Agronomics is a VC fund in Douglas focused on Biotechnology and Food and Beverage. Port Erin Biopharma Investments Limited (LSE: PEBI), incorporated on 3 May 2011 under the law of the Isle of Man for the purposes of investing in the Biotechnology and Biopharmaceutical sector.The Company's strategy is to create value for Shareholders through investing in companies that have the potential to generate substantial revenuesthrough the development of biopharmaceutical drugs.The Company's Non-Executive Chairman is Jim Mellon, who has had a successful career in the fund management industry.The Company intends to co-invest wherever possible alongside Mr Mellon in investments that he has identified.
- Total investments:
- 48
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Agronomics invests in
Stages Agronomics invests in
Countries Agronomics invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $894k–$11M
- Series A
- $6M–$47M
- Series B
- $2.4M–$55M
Investment Focus
Industry
- Biotechnology 15 (31%)
- Food and Beverage 13 (27%)
- Food Processing 8 (17%)
- Agriculture 4 (8%)
- Alternative Protein 4 (8%)
Stage
- Seed 13 (27%)
- Series A 12 (25%)
- Series B 6 (13%)
- Convertible Note 4 (8%)
- Venture - Series Unknown 3 (6%)
Country
- United States 10 (21%)
- United Kingdom 3 (6%)
- Finland 2 (4%)
- Germany 2 (4%)
- Australia 2 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Anthony Chow
Co-Founder
|
Co-Founder | Total investments: 0 | Find email | |
Jim Mellon
Founder
|
Founder | Total investments: 35 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in acontrolled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century. | $6M / Series A / May 12, 2026 | ||
| Meatly provides cultivated meat made specifically for pets. | $14.1M / Series A / May 07, 2026 | ||
| BlueNalu is a cellular aquaculture company that satisfies the global appetite for seafood in a fresh, sustainable, and humane way. It offers consumers with great tasting, healthy, safe, and trusted seafood products, that support the sustainability and diversity of the oceans. | $6M / Venture - Series Unknown / Dec 29, 2025 | ||
| BlueNalu is a cellular aquaculture company that satisfies the global appetite for seafood in a fresh, sustainable, and humane way. It offers consumers with great tasting, healthy, safe, and trusted seafood products, that support the sustainability and diversity of the oceans. | $8M / Convertible Note / Dec 29, 2025 | ||
| Called All G Foods, the company uses technology to develop dairy proteins that can be included in milk and other “cow-free” dairy products, as well as to enhance its incoming plant-based meat ranges. | $6.6M / Convertible Note / Dec 09, 2025 | ||
| SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in acontrolled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century. | $3.5M / Seed / Nov 21, 2025 | ||
| Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech. | $31.5M / Convertible Note / Jan 30, 2025 | ||
| Rebellyous Foods is a food manufacturing technology and production company defined solely to catapult meat alternative production toward price parity with animal-based meat. Rebellyous Foods implements food manufacturing equipment and processes in large-scale production to produce low-cost plant-based meat at high volumes. These goals are achievedthrough uniquely designed food products, the use of high-throughput manufacturing automation and ‘smart’ production centers, and the development and utilization of new innovative low-energy manufacturing tools.Rebellyous Foods was established in 2017 in Seattle, Washington. | $2.4M / Series B / Jan 09, 2025 | ||
| Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech. | $2M / Convertible Note / Oct 15, 2024 | ||
| GALY develops biomaterials through biotechnology and synthetic biology in order to discover new ways to produce natural things. The company was founded in 2016 and is headquartered in Amherst, Massachusetts. | $33M / Series B / Sep 03, 2024 | ||
| See all 48 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Agronomics invest in?
Agronomics invests primarily in Biotechnology, Food and Beverage and Food Processing startups, most often at Seed and Series A stage. Most of the 48 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Agronomics's check size?
Agronomics typically joins rounds of $894k–$11M at Seed, $6M–$47M at Series A and $2.4M–$55M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Agronomics participates in.
How do I contact Agronomics?
Public channels for Agronomics include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Agronomics?
The team at Agronomics includes Anthony Chow (Co-Founder) and Jim Mellon (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
